CPC A61K 31/295 (2013.01) [A61P 7/06 (2018.01)] | 34 Claims |
1. A method of treating iron deficiency in a human subject, which comprises administering a dose followed by a further dose of ferric carboxymaltose to the subject, wherein:
a. the dose of ferric carboxymaltose contains 750 mg of elemental iron and the further dose of ferric carboxymaltose contains 750 mg of elemental iron; or
b. the dose of ferric carboxymaltose contains 1000 mg of elemental iron and the further dose of ferric carboxymaltose contains in the range of 500 mg to 1000 mg of elemental iron,
wherein the subject has a reduced risk for hypophosphatemia, wherein the subject having a reduced risk for hypophosphatemia has a normal serum phosphate level.
|